Teva Generic Versions Of Focalin Clear FDA With 180-Day Exclusivity
This article was originally published in The Pink Sheet Daily
Executive Summary
The approval includes 2.5 mg, 5 mg and 10 mg formulations of dexmethylphenidate tabs for ADHD.
You may also be interested in...
Novartis Files Suit To Block Barr From Marketing Generic Ritalin LA
Barr’s ANDA with Paragraph IV certification was accepted by FDA in September, generics firm says.
Novartis Files Suit To Block Barr From Marketing Generic Ritalin LA
Barr’s ANDA with Paragraph IV certification was accepted by FDA in September, generics firm says.
Shire Anticipates Vyvanse Approval In “Next Month Or Two”
The firm is considering a marketing partner and aims to replace its ADHD treatment Adderall XR with Vyvanse.